Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Pidotimod injection for AECOPD adjunctive therapy (phase II)
CTR20150357Phase 2Active
- Sponsor
- Shenyang Shuangding Pharmaceutical
- Start
- Jun 2015
- Modality
- Small Molecules, Peptides
- Countries
- 1
01
Overview
A Phase 2 trial of pidotimod in chronic obstructive pulmonary disease (COPD), sponsored by Shenyang Shuangding Pharmaceutical. Started Jun 2015; status: active.
02
Drugs
pidotimod
03
Conditions
chronic obstructive pulmonary disease (COPD)
Beyond the preview
Go deeper on CTR20150357.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20150357.